Navigation Links
FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
Date:6/27/2008

to explore other new therapies to meet the needs of children and the pediatric community. Visit http://www.mcneilpediatrics.net for more information.

About J&JPRD

Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) is part of Johnson & Johnson, the world's most broadly based producer of healthcare products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Asia, Europe and the United States. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

References

(1) Wilens, T.E., Dodson, W. A Clinical Perspective of Attention-Deficit Hyperactivity Disorder into Adulthood. Journal of Clinical Psychology 65:10. October 2004.

(2) National Institute of Mental Health. "ADHD in Adults." Available at http://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity- disorder-adhd/index.shtml. Accessed June 19, 2008.

(3) Wilens, T.E., Biederman J., Spencer T.J. Attention Deficit/Hyperactivity Disorder Across the Lifespan. Annual Review of Medicine, Vol. 53. 2002.

(4) National Institute of Mental Health. "Genetics." Available at http://www.nimh.nih.gov/health/publications/adhd/attention-deficit- hyperactivity-disorder-in-adults.shtml. Accessed June 19, 2008.

Media Investors

Tricia Geoghegan: (609) 730-3746 Louise Mehrotra: (732) 524-6491

tgeogheg@janus.jnj.com Johnson & Johnson

Lesley Fishman: (732) 524-3922

Johnson & Johnson


'/>"/>
SOURCE Johnson & Johnson Pharmaceutical Research & DevelopmentL.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
2. Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
3. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
4. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
5. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
6. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
7. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
8. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
9. Medicare Approves in Home Sleep Apnea Testing
10. 3SBio Inc. Approves Share Repurchase Program
11. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA), which ... 2014 to seven, with eighteen submissions now pending at ... President and CEO of the Company, commented, "Our team ...
(Date:11/24/2014)... SOUTH SAN FRANCISCO, Calif. , Nov. 24, 2014 /PRNewswire/ ... announced that Bonnie H. Anderson , president and chief ... the Piper Jaffray 26 th Annual Healthcare Conference on ... New York . The live audio ... website at http://investor.veracyte.com . Please connect to the website ...
(Date:11/24/2014)... 2014  Spherix Incorporated (Nasdaq: SPEX ... fostering and monetization of intellectual property, today provided ...  Case No. 3:13-cv-03494-M and  Spherix v. Uniden Corporation ... the United States District Court for the Northern ... On November 21, 2014 the Markman ...
(Date:11/22/2014)... Prominent academics, leaders of the ... December 3rd at Genetic Rx, a networking conference ... take place at the Joseph B. Martin Conference ... the present and future of genetic medicines—including siRNA, ... editing—as well as the treatment of patients with ...
Breaking Biology Technology:IGI Laboratories, Inc. Announces ANDA Submission 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2
... May 5 Silence Therapeutics plc (AIM: ... Jorg Kaufmann , Ph.D., to the position of ... Kaufmann, who previously served as senior director, technologies at ... Company,s broad range of RNA interference (RNAi) research activities, ...
... Healthcare ... Finance and Administration. Mr. Wilson brings over 25 years experience in this field and ... ... Mitchell Wilson has joined the company as Vice President of Finance and Administration. Mr. ...
... Inc. (Nasdaq: ITMN ) today announced that the U.S. Food and ... Application (NDA) for Esbriet™ (pirfenidone) for the treatment of patients with idiopathic ... , , ... the FDA,s Center for Drug Evaluation and Research when the review of ...
Cached Biology Technology:Silence Therapeutics Appoints New Vice President of Research 2Silence Therapeutics Appoints New Vice President of Research 3Healthcare Data Solutions Announces New Executive Team Member 2InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 2InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 3InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 4InterMune Receives FDA Complete Response Letter on Esbriet(TM) (Pirfenidone) New Drug Application 5
(Date:11/4/2014)... death at the right time might actually help boost ... could help in understanding animal populations, pest control and ... in the journal Trends in Ecology and Evolution ... that the kind of positive population effect an overall ... depends on the size and developmental stage of the ...
(Date:11/4/2014)... 4, 2014) — Think about the way our bodies ... neighboring cells know that they are supposed to become ... these tissues find the correct place and alignment? Researchers ... crucial questions. , In a new study, UM researchers ... with their surrounding neighbors, at the head-trunk region. Their ...
(Date:11/4/2014)... OXFORD, England , November 4, 2014 ... expansion and vertical market growth   Fuel3D ... it has closed a funding round totaling $6.4 million (£4 ... (£1.6 million) funding secured earlier this year and paves the ... product in 2015. The funding round was led ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... article by Stevens Institute of Technology researchers featured as ... Volume 98, Issue 7 represents a step forward in ... Dr. Chang-Hwan Choi and Dr. Eui-Hyeok (EH) Yang, and ... focuses on nanowires, structures that are mere nanometers in ...
... Ga., Feb. 23, 2011 MiMedx Group, Inc. (OTC ... manufacturer and marketer of patent protected biomaterial-based products, announced ... full year ended December 31, 2010, and Company guidance ... on Monday, March 28, 2011.  The timing of the ...
... awarded a prestigious Sloan Research Fellowship. Chen, a Canada ... subject: deciphering the assembly instructions for the brain. ... with precision. One of the central puzzles in neuroscience ... during its development when faced with thousands of potential ...
Cached Biology News:Nanowire research at Stevens makes cover of Applied Physics Letters 2MiMedx Group, Inc. Announces Release Date for 2010 Fourth Quarter and Full Year Results 2Prestigious Sloan Fellowship awarded 2
... Instech Solomon's laboratory animal infusion kits reduce ... an infusion study while providing sterile equipment ... kit includes everything you need for one ... Tubing and tethers will be cut to ...
... Plus is a small and ... market for both LC and IC. It ... Atmospheric Pressure Ionization (API) source for outstanding ... is compatible with existing LC and IC ...
Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s)....
...
Biology Products: